[Monogenic diabetes: a useful dimension for diabetology practice].
The number of identified monogenic diabetes progressively increases with time even if these forms of diabetes represent less than 5% of the cases. Every monogenic diabetes is characterized by an impairment of Beta cell at various levels. They are good models of diabetes-prone mechanisms. Diabetologists should recognize these forms because the management of the patients could be modified as a function of the genetic anomaly, in terms of either choice of hypoglycaemic agents, prognostic, management of associated manifestations or genetic counselling.
Valéro
R
R
Service de Nutrition, Maladies métaboliques et Endocrinologie, Hôpital de la Timone, CHU de Marseille, rue Saint-Pierre, 13005 Marseille.
Béliard
S
S
Paquis-Fluckinger
V
V
Vialettes
B
B
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000235:genetics*; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000503:physiopathology; D008957:Models, Genetic; D014929:Wolfram Syndrome / Q000235:genetics
D007004:Hypoglycemic Agents